There could be a crisis in science, especially in the social and even medical sciences: Results are difficult to reproduce. Groundbreaking papers might reveal a first set of results, but attempts to repeat the studies reveal a different and sometimes even conflicting new set.
An unproven stem cell therapy conducted by a Florida clinic has blinded three patients in an apparent clinical trial gone horribly wrong. The incident showcases the extent to which unscrupulous clinics will take advantage of desperate patients — and how the lack of government oversight contributes to the problem.
Just days after shutting down tests of a groundbreaking new cancer therapy in the wake of three patient deaths, the US Food and Drug Administration has said the trials can resume. So what changed?